# A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)

> **NCT06903715** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Belzutifan
- **DRUG:** Phenytoin

## Key facts

- **NCT ID:** NCT06903715
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-28
- **Primary completion:** 2025-05-08
- **Final completion:** 2025-05-27
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06903715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06903715, "A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06903715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*